Halozyme Therapeutics shares owned by Schroder Investment Management Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Schroder Investment Management Group
from 13F filings
Historical chart of Schroder Investment Management Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Schroder Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $763k | 15k | 52.36 |
| 2024-03-31 | $6.7M | 166k | 40.68 |
| 2023-12-31 | $2.3M | 62k | 36.96 |
| 2023-06-30 | $648k | 18k | 36.07 |
| 2023-03-31 | $20M | 535k | 38.19 |
| 2022-12-31 | $5.9M | 103k | 56.90 |
| 2022-09-30 | $1.6M | 41k | 39.54 |
| 2021-09-30 | $3.4M | 82k | 41.24 |
| 2021-06-30 | $30M | 653k | 45.40 |
| 2021-03-31 | $23M | 557k | 41.69 |
| 2020-12-31 | $4.8M | 113k | 42.72 |
| 2020-09-30 | $3.7M | 143k | 25.80 |
| 2018-03-31 | $1.5M | 77k | 19.59 |
| 2017-12-31 | $2.0M | 98k | 20.26 |
More positions owned by Schroder Investment Management Group
View all positions for Schroder Investment Management Group